跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NIFECARD XL TABLET 30 mg - HSA Drug Approval Details
Approvals
/
HSA
/
NIFECARD XL TABLET 30 mg
Approved
THERAPEUTIC
NIFECARD XL TABLET 30 mg
LEK PHARMACEUTICAL D.D.LEK PHARMACEUTICALS D.D, LENDAVA (Primary and Secondary Packager)
🇸🇬 Health Sciences Authority
Approval Date
Nov 16, 2001
Approval ID
df53f0cd62d50bff
Company
LEK PHARMACEUTICAL D.D.LEK PHARMACEUTICALS D.D, LENDAVA (Primary and Secondary Packager)
Type
Therapeutic
Approval Details
Approval Id
df53f0cd62d50bff
Drug Name
NIFECARD XL TABLET 30 mg
Product Name
NIFECARD XL TABLET 30 mg
Approval Number
SIN11720P
Approval Date
2001-11-16
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
C08CA05
Atc Item Name
nifedipine
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
NIFEDIPINE
30 mg
NIFEDIPINE
30 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 16, 2001
Approval ID
df53f0cd62d50bff
Type
Therapeutic
Back to HSA Approvals